California
Duarte; City of Hope
Phase II Trial Utilizing Idarubicin in Combination with High-Dose Ara-C for Induction Therapy for Adult Acute Myelogenous Leukemia
Duarte; City of Hope
COG AALL03N1: Understanding the Ethnic and Racial Differences in Survival in Children with Acute Lymphoblastic Leukemia
Duarte; City of Hope
SWOG 9007: Cytogenetic Studies In Leukemia Patients
Duarte; City of Hope
Understanding the Barriers and Facilitators to Adherence to Oral Chemotherapy in Youth with Acute Lymphoblastic Leukemia
Duarte; City of Hope
A Phase II Multicenter Trial of Myeloablative Double Unit Umbilical Cord Blood Transplantation (UCBT) in Adults with Hematologic Malignancy
Duarte; City of Hope
PHI-57 NCI# 7689: Phase I Trial of GTI2040 in Relapsed, Refractory, or High Risk Leukemia and Myelodysplasia
Duarte; City of Hope
PHI-47 NCI#6581: Phase I Trial of R115777 (NSC 702818) In Relapsed, Refractory or High-Risk Myeloid Leukemia
Duarte; City of Hope
PHI-48 NCI#6777: Phase I and Pharmacodynamic Study of SB-715992 in Acute Leukemia
Duarte; City of Hope
COG AALL0232: High Risk B-Precursor Acute Lymphoblastic Leukemia
Duarte; City of Hope
SWOG S0333: A Phase II Study of Double Induction Chemotherapy for Newly Diagnosed Non-L3 Adult Acute Lymphoblastic Leukemia with Investigation of Minimal Residual Disease and Risk of Relapse Following Maintenance Chemotherapy
Duarte; City of Hope
A Phase II Study of Rituximab-ABVD in Classical Hodgkin's Lymphoma
Duarte; City of Hope
Molecular Pathogenesis of Therapy-Related Leukemia
Duarte; City of Hope
T2005-003: A Study of Bortezomib with Chemotherapy for Relapsed/Refractory Acute Lymphoblastic Leukemia
Duarte; City of Hope
COG AALL03B1: Classification of Acute Lymphoblastic Leukemia
Duarte; City of Hope
Immunophenotype and Function of Bone Marrow-Infiltrating Lymphocytes in Patients with Myeloid Leukemias
Duarte; City of Hope
Mechanisms of Response and Resistance to STI571 in CML
Duarte; City of Hope
SWOG S9910: Leukemia Centralized Reference Laboratories and Tissue Repositories, Ancillary
Duarte; City of Hope
Acquisition of Leukapheresed Peripheral Blood Mononuclear Cells from Healthy Donors for use as Support Cells in Ex-Vivo T Cell Expansions
Duarte; City of Hope
Molecular Pathogenesis of Acute Leukemia and Myelodysplasia
Duarte; City of Hope
Phase I/II Study of SKI-606 in Philadelphia Chromosome Positive Leukemias (Wyeth No. 3160A1-200-US)
Duarte; City of Hope
A Phase I Clinical Trial of Vorinostat in Combination with Decitabine in Patients with Acute Myelogenous Leukemia or Myelodysplastic Syndrome
Duarte; City of Hope
BMT CTN 0303: A Single Arm, Multicenter Phase II Trial of Transplants of HLA-Matched, CD34+Enriched, T Cell Depleted Peripheral Blood Stem Cells Isolated by The CliniMACS System in The Treatment of Patients With AML in First or Second Morphologic Complete Remission
Duarte; City of Hope
COG AALL0331: Standard Risk B-Precursor Acute Lymphoblastic Leukemia
Duarte; City of Hope
Allogeneic Stem Cell Transplantation with a Novel Conditioning Therapy Helical Tomotherapy, Melphalan, and Fludarabine in Acute Myelogenous Leukemia
Indiana
Beech Grove; American Health Network of Indiana LLC, Oncology Division
Phase II Trial of Cloretazine in Elderly Patients with Poor Risk de novo AML
Beech Grove; American Health Network of Indiana LLC, Oncology Division
Phase III: Randomized, Double Blind, Controlled Comparison of Clofarabine and Cytarabine vs Cytarabine Alone in Adult Patients ? 60 years old with AML who have Relapsed or are Refractory after Receiving up to Two Prior Induction Regimens
Indianapolis; American Health Network of Indiana LLC, Oncology Division
First or second line treatment for chronic lymphocytic leukemia (CLL) utilizing nipent, cytoxan and rituxan.
Massachusetts
Boston; Boston University Medical Center
Dendritic/AML Fusion Cell Vaccine Therapy for AML Patients in First Remission: A Phase I Clinical Trial.
New York
Bronx; Biomedical Research Alliance of New York
Leukemia - Refractory/Relapsed Acute Myelogenous
Bronx; Biomedical Research Alliance of New York
Acute Lymphocytic Leukemia (ALL) - Refractory or Relapsed
Bronx; Biomedical Research Alliance of New York
Leukemia - Acute Lymphocytic (ALL)
Lake Success; Biomedical Research Alliance of New York
Acute Promyelocytic Leukemia (APL) - Adults
Manhasset; Biomedical Research Alliance of New York
An experimental study to determine the dosage and safety of a study drug in patients with leukemia.
New Hyde Park; Biomedical Research Alliance of New York
A study to evaluate the tolerability of a study drug to help people with B-cell lymphocytic leukemia (B-CLL)
New York; Mount Sinai Medical Center
Randomized Phase II Study of Thalidomide Versus Thalidomide Plus Fludarabine for Patients with Chronic Lymphocytic Leukemia Previously Treated with Fludarabine
New York; Columbia-Presbyterian Medical Center
Study of donor leukocyte infusions in patients with recurrent or persistent hematological malignancies after allogeneic bone marrow transplantation.
New York; Columbia-Presbyterian Medical Center
Study of the use of peripheral blood stem cells for allogeneic transplantation (PBSCT) in patients with advanced hematological malignancies at increased risk of relapse or transplant-related mortality
New York; Columbia-Presbyterian Medical Center
Study of autografting for advanced phase chronic myeloid leukemia
New York; Columbia-Presbyterian Medical Center
Study of transplantation using umbilical cord and placental blood
New York; Mount Sinai Medical Center
A Phase I-II Pilot Study of Divalproex Sodium and All-Trans-Retinoic Acid (ATRA) in Relapsed or Refractory Acute Myeloid Leukemia (except M3, FAB Classification)
New York; Columbia University Medical Center
Peripheral Blood Stem Cell Mobilization and Storage in Patients with Chronic Myelogenous Leukemia in Complete Cytogenetic Remission on Imatinib.
New York; Biomedical Research Alliance of New York
Chronic Lymphocytic Leukemia
New York; Biomedical Research Alliance of New York
Mount Sinai Medical Center is recruiting subjects with chronic myeloid leukemia who are in blast crisis, accelerated phase, or chronic phase to participate in a clinical study to determine the safety of an experimental drug.
Ohio
Cincinnati; Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation
A Phase II Study of Rituximab and Ifosfamide, Carboplatin and Etoposide (ICE) Chemotherapy In Children with Recurrent/Refractory B-cell (CD20+) Non-Hodgkin Lymphoma and B-cell Acute Lymphoblastic Leukemia
Cincinnati; Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation
A Feasibility Pilot and Phase 2 Study of Chemoimmunotherapy with Epratuzumab for Children with Relapsed CD22-Positive Acute Lymphoblastic Leukemia
Cincinnati; Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation
High Risk B- Precursor Acute Lymphoblastic Leukemia Study
Texas
Houston; S. R. Burzynski Clinic
Phase II Study Of Antineoplastons A10 And AS2-1 In Patients With Chronic Myelogenous Leukemia
Houston; S. R. Burzynski Clinic
Phase II Study Of Antineoplaston A10 And AS2-1 In Patients With Chronic Lymphocytic Leukemia
